The 28th Annual Meeting of Japan Society of Gene and Cell Therapy

Presentation information

Print

Oral Session

[OR4] Oral Session Ⅳ Vectors①

Thu. Jul 14, 2022 4:42 PM - 6:18 PM Room 3 (3F 304)

Chair persons : Masashi Urabe (Division of Genetic Therapeutics, Jichi Medcal University), Hiromi Hayashita-Kinoh ( Division of Molecular and Medical Genetics, Center for Gene and Cell Therapy,The Institute of Medical Science, The University of Tokyo)

[OR-28] A novel engineered AAV2 capsid variant CereAAV for efficient in vivo gene transduction into mouse brain neurons and microvascular endothelial cells.

Yoshinori Tanaka (Takarabio Inc.)

Abstract password authentication.
The password was sent to all registrants in email. You can also check it in abstracts and a live streamig site.

Password